Cintas exec Rozakis reports option awards and multiple stock transactions

Rhea-AI Filing Summary

Jim Rozakis, Executive Vice President & COO of Cintas Corporation (CTAS), reported multiple equity transactions dated 08/11/2025. The filing shows a grant of 6,852 restricted shares under the company’s equity compensation plan and several stock option awards totaling 69,302 options across five strike prices.

The option awards listed include 23,326 options at $223.88 (expiration 08/11/2035), 16,900 at $97.22 (07/27/2031), 13,884 at $99.46 (07/26/2032), 6,920 at $61.99 (05/29/2030) and 8,272 at $73.39 (07/26/2030). The filing also records several dispositions of common stock (amounts reported: 11,545, 9,563, 4,118, 5,158). Post-transaction beneficial ownership figures in the filing range from 259,521 to 280,271 shares, with 2,784 shares held indirectly via a 401(k) plan.

The accompanying disclosure explains the restricted shares were granted under the Equity Compensation Plan and the options vest in thirds on the third, fourth and fifth anniversaries of the grant date.

Positive

• 6,852 restricted shares granted under the Cintas Equity Compensation Plan
• 69,302 stock options awarded across five strike prices, supporting multi-year executive alignment
• Explicit vesting schedule: one-third on the third, fourth and fifth anniversaries

Negative

• Multiple share dispositions reported (11,545; 9,563; 4,118; 5,158) without explanation in the filing
• Post-transaction beneficial ownership varies across reported lines (range 259,521 to 280,271), creating multiple snapshot figures rather than a single consolidated ownership total

Insights

Financial Analyst

TL;DR: Routine executive equity awards and several share dispositions were reported; no operational or balance-sheet changes disclosed.

The Form 4 discloses compensation-related equity activity for CTAS leadership rather than corporate events. Total option awards equal 69,302 options across five exercise prices, and 6,852 restricted shares were granted. Several share dispositions are reported in discrete amounts. These items affect executive ownership and potential future dilution from option exercise, but the filing contains no information about company performance or material corporate developments.

Compensation/Governance Specialist

TL;DR: Grants use multi-year vesting and a 10-year option term for at least one award; the filing documents awards and dispositions without stated rationale.

The awards include standard equity instruments: restricted shares under the Equity Compensation Plan and multiple stock option grants with explicit exercise prices and expiration/ exercisability dates. The vesting schedule—one-third on the third, fourth and fifth anniversaries—ties value realization to multi-year retention. The filing lists specific disposition amounts but provides no explanation for those sales or transfers.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rozakis Jim

(Last) (First) (Middle)

6800 CINTAS BLVD

(Street)

CINCINNATI OH 45262

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CINTAS CORP [ CTAS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Exec. Vice President & COO

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2025		A		6,852(1)	A	$223.88	259,521	D
Common Stock	08/11/2025		M		16,900	A	$97.22	276,421	D
Common Stock	08/11/2025		F		11,545	D	$223.77	264,876	D
Common Stock	08/11/2025		M		13,884	A	$99.46	278,760	D
Common Stock	08/11/2025		F		9,563	D	$223.77	269,197	D
Common Stock	08/11/2025		M		6,920	A	$61.99	276,117	D
Common Stock	08/11/2025		F		4,118	D	$223.7	271,999	D
Common Stock	08/11/2025		M		8,272	A	$73.39	280,271	D
Common Stock	08/11/2025		F		5,158	D	$223.68	275,113	D
Common Stock								2,784	I	By 401(k) plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$223.88	08/11/2025		A		23,326		(2)	08/11/2035	Common Stock	23,326	$0	23,326	D
Stock Option (Right to Buy)	$97.22	08/11/2025		M			16,900	(2)	07/27/2031	Common Stock	16,900	$0	16,900	D
Stock Option (Right to Buy)	$99.46	08/11/2025		M			13,884	(2)	07/26/2032	Common Stock	13,884	$0	27,772	D
Stock Option (Right to Buy)	$61.99	08/11/2025		M			6,920	(2)	05/29/2030	Common Stock	6,920	$0	0	D
Stock Option (Right to Buy)	$73.39	08/11/2025		M			8,272	(2)	07/26/2030	Common Stock	8,272	$0	0	D

Explanation of Responses:

1. Restricted shares granted pursuant to Cintas Corporation Equity Compensation Plan.

2. The options vest as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date and one-third on the fifth anniversary of the grant date.

	/s/ Allison A. Westfall as Attorney-in-Fact for Jim Rozakis	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Jim Rozakis report on 08/11/2025 for CTAS?

The Form 4 reports a grant of 6,852 restricted shares, multiple stock option awards totaling 69,302 options at various exercise prices, and several common stock dispositions (amounts: 11,545, 9,563, 4,118, 5,158).

How many stock options were granted to Jim Rozakis and at what exercise prices?

Options reported total 69,302: 23,326 at $223.88, 16,900 at $97.22, 13,884 at $99.46, 6,920 at $61.99, and 8,272 at $73.39.

What is the vesting schedule for the awarded options?

The filing states the options vest in thirds: one-third on the third anniversary of the grant date, one-third on the fourth anniversary, and one-third on the fifth anniversary.

How many shares does Rozakis beneficially own after the reported transactions?

The filing lists post-transaction beneficial ownership figures on individual lines ranging from 259,521 to 280,271 shares; additionally, 2,784 shares are reported as indirectly held via a 401(k) plan.

Does the Form 4 explain reasons for the share dispositions?

No. The filing records the disposition amounts but does not provide reasons or context for those sales or transfers.